Refine
Has Fulltext
- yes (352)
Is part of the Bibliography
- yes (352)
Year of publication
Document Type
- Journal article (251)
- Doctoral Thesis (71)
- Preprint (30)
Language
- English (352) (remove)
Keywords
- Anorganische Chemie (64)
- boron (55)
- Boron (16)
- diborenes (15)
- borylation (14)
- luminescence (13)
- fluorescence (12)
- inorganic chemistry (12)
- Chemie (9)
- boranes (9)
- carbenes (9)
- density functional calculations (9)
- structure elucidation (9)
- Bor (8)
- N-heterocyclic carbenes (8)
- DFT (7)
- aromaticity (6)
- diborynes (6)
- heterocycles (6)
- Übergangsmetallkomplexe (6)
- Borylene (5)
- Borylierung (5)
- borylene (5)
- chemistry (5)
- copper (5)
- cross-coupling (5)
- fluorine (5)
- hydroboration (5)
- radical (5)
- single-crystal X-ray study (5)
- Übergangsmetall (5)
- Borylation (4)
- Chemistry (4)
- Diborane (4)
- Dichtefunktionalformalismus (4)
- Fluoreszenz (4)
- Konjugierte Polymere (4)
- Lewis acids (4)
- Rhodium (4)
- Triarylborane (4)
- bismuth (4)
- boronate esters (4)
- catalysis (4)
- complexes (4)
- crystal structure (4)
- dehydrocoupling (4)
- diborane (4)
- diboranes (4)
- diborene (4)
- fluoroarene (4)
- radicals (4)
- singlet oxygen (4)
- triarylborane (4)
- BN compounds (3)
- Borane (3)
- Carbene (3)
- Catalysis (3)
- Chemische Synthese (3)
- Cycloaddition (3)
- EPR (3)
- Elektronenspinresonanz (3)
- Heterocyclische Carbene <-N> (3)
- Multiple bonds (3)
- Muscarinic receptor subtypes (3)
- Muscarinic receptors (3)
- NHC (3)
- Silicium (3)
- bond activation (3)
- boronate (3)
- borylenes (3)
- carbene ligands (3)
- cationic species (3)
- cell imaging (3)
- chalcogens (3)
- chromophore (3)
- diboration (3)
- fluorescent probes (3)
- homogeneous catalysis (3)
- ionic liquids (3)
- low-valent compounds (3)
- main group elements (3)
- multiple bonds (3)
- muscarinic receptor subtypes (3)
- photophysics (3)
- platinum (3)
- polycycles (3)
- pyrene (3)
- small-molecule activation (3)
- synthetic methods (3)
- two-photon absorption (3)
- Aromaticity (2)
- Aromatizität (2)
- Biradicals (2)
- Boranes (2)
- Borverbindungen (2)
- Borylenkomplexe (2)
- C-H activation (2)
- Cyclization (2)
- DFT calculations (2)
- DNA/RNA sensors (2)
- Difenidol (2)
- EDA-NOCV (2)
- EPR spectroscopy (2)
- Eisenkomplexe (2)
- Elektronendichte (2)
- Elektronendichteverteilung (2)
- Fluorescence (2)
- Fotophysik (2)
- Furylborane (2)
- Gallium (2)
- Halbsandwich-Verbindungen (2)
- Heterocyclen (2)
- Heterocycles (2)
- Heterocyclische Verbindungen (2)
- Hexahydro-sila-difenidol analogues (2)
- Hypervalentes Molekül (2)
- Kohlenmonoxid (2)
- Koordinationslehre (2)
- Lewis acidity (2)
- Ligand (2)
- Lumineszenz (2)
- Main-group chemistry (2)
- Multipolverfeinerung (2)
- Muscarinic receptor antagonists (2)
- N ligands (2)
- N-Heterocyclic Carbenes (2)
- N-heterocyclic carbene (2)
- Nickelkomplexe (2)
- Phosphine (2)
- Polyimido Anions (2)
- Polyimidoanionen (2)
- R factor = 0.027 (2)
- Radikal <Chemie> (2)
- Räumliche Verteilung (2)
- Schwefelylide (2)
- Silanole (2)
- Silicon (2)
- Silicon-Boron Exchange (2)
- Silizium-Boraustausch (2)
- Stereoselectivity (2)
- Sulfur Ylides (2)
- T = 100 K (2)
- Topologie (2)
- Transition metals (2)
- UV/Vis spectroscopy (2)
- Wolfram (2)
- Wolframkomplexe (2)
- ab initio calculations (2)
- aminotroponiminates (2)
- animals (2)
- antimony (2)
- biological activity (2)
- bonding (2)
- boronates (2)
- boronic acid (2)
- borylene complexes (2)
- cAArC (2)
- carbon monoxide (2)
- carborane (2)
- cations (2)
- charge density (2)
- charge transfer (2)
- chemical bonding (2)
- chirality (2)
- circular dichroism (2)
- computational chemistry (2)
- conjugation (2)
- coordination polymers (2)
- cyanoborate (2)
- cyanoborates (2)
- cyclic (alkyl)(amino)carbenes (2)
- cycloaddition (2)
- diazadiborinines (2)
- diradicals (2)
- electrochemistry (2)
- electron density distribution (2)
- electrophilic substitution (2)
- g-Tensor (2)
- g-tensor (2)
- helicene (2)
- hybrid materials (2)
- hydrogenation (2)
- imidazolate (2)
- ligands (2)
- low-valent main group chemistry (2)
- lysosome (2)
- main group element halides (2)
- main-group chemistry (2)
- manganese (2)
- multiple bonding (2)
- multipole refinement (2)
- nickel (2)
- o-methoxy-sila-hexocyclium (2)
- one-electron oxidation (2)
- organic chemistry (2)
- oxidative addition (2)
- palladium (2)
- parasympatholytics (2)
- pentacoordinate (2)
- phosphorescence (2)
- pi-conjugation (2)
- piperidines (2)
- polycyclic aromatic hydrocarbons (2)
- quantitative analysis (2)
- radical reactions (2)
- reaction mechanism (2)
- redox (2)
- ring expansion (2)
- ring-expansion reaction (2)
- silahexocyclium (2)
- theranostics (2)
- titanium (2)
- topology (2)
- transition metal complex (2)
- two-photon excited fluorescence (2)
- wR factor = 0.068 (2)
- weakly coordinating anions (2)
- zwitterionic (2)
- (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride/pharmacology (1)
- (R)- and (S)-hexahydro- / Antimuscarinic properties / Muscarinic receptor subtypes (1)
- (± )-dioncophyllacine A (1)
- 1,2-additionreaction (1)
- 1,2-additions (1)
- 1,2-azaborinine (1)
- 1,4-Diborabenzene (1)
- 2,5-diketopiperazines (1)
- 2-alkylbranched acids (1)
- 2n+3 (1)
- 3-coordinate boron (1)
- 3-coordinate organoboron compounds (1)
- 4-dimethylamino-4′-cyanodiphenylacetylene (1)
- 9-borafluorene (1)
- ACID (1)
- AF-DX 116 (1)
- AIE (1)
- AIM (1)
- Acene (1)
- Activation (1)
- Addukt (1)
- Aldehyde Complexes (1)
- Alkine (1)
- Alkohol (1)
- Alkyl(amino)carbene (1)
- Alkyne (1)
- Aluminium (1)
- Aluminiumhydridderivate (1)
- Aminosäuren (1)
- Anorganische Polymere (1)
- Antagonist (1)
- Antibacterial therapy (1)
- Antibacterials (1)
- Antibiotic resistance (1)
- Antibiotics (1)
- Aromaten (1)
- Aromatic Systems (1)
- Arrhenius equation (1)
- Arterioles (submucosal) (1)
- Aryl Halides (1)
- Arylborylene Complexes (1)
- Arzneimittel (1)
- Atomic and molecular interactions with photons (1)
- Atomisierungsenergien (1)
- Autoradiography (1)
- B,N-heterocycles (1)
- B,N-heterocylcles (1)
- B-B bond (1)
- B-B bond activation (1)
- BB bond activation (1)
- BB/BC Bond activation (1)
- BC bond activation (1)
- BP compounds (1)
- BSA (1)
- Bacterial pathogens (1)
- Benzimidazole (1)
- Benzothiazolderivate (1)
- Benzyne (1)
- Beryllium (1)
- Bexaroten (1)
- Bindungsaktivierung (1)
- Bindungsanalyse (1)
- Bindungspolarisation (1)
- Bioanorganische Chemie (1)
- Bioisosterie (1)
- Biokonjugate (1)
- Biolabelling (1)
- Biologische Aktivität (1)
- Biologisches System (1)
- Biomacromolecular Sensing (1)
- Bioorganometallchemie (1)
- Bioorganosilicon chemistry (1)
- Bioradicals (1)
- Bioradikale (1)
- Biradikale (1)
- Birds (1)
- Bis-diimidosulfinate (1)
- Bis-diimidosulfinates (1)
- Bis-triimidosulfonate (1)
- Bis-triimidosulfonates (1)
- Bismut (1)
- Bismuth (1)
- Bor-Phosphor-Verbindungen (1)
- Bor-Stickstoff Bindung (1)
- Bor-Stickstoff-Verbindungen (1)
- Boracumulen (1)
- Boracumulene (1)
- Boraheterocycles (1)
- Boration (1)
- Borazin (1)
- Borheterocyclen (1)
- Borole (1)
- Boron Chemistry (1)
- Boron Materials (1)
- Bororganische Verbindungen (1)
- Borsäureester (1)
- Borylene complexes (1)
- B–C coupling (1)
- B–C-Kupplung (1)
- B−H activation (1)
- C-C coupling (1)
- C-Cl (1)
- C-F (1)
- C-H (1)
- CH activation (1)
- CO activation (1)
- CO-releasing molecules (1)
- CO2 fixation (1)
- CORM (1)
- CORMs (1)
- CO‐releasing molecules (CORMs) (1)
- CPP Peptide (1)
- CPP-peptide (1)
- Carbachol-induced drinking (1)
- Carbenes (1)
- Carbon Monoxide (1)
- Chalkogene (1)
- Chemical Synthesis (1)
- Chemische Bindung (1)
- Click-Chemie (1)
- Copper (1)
- Copper catalysis (1)
- Coupled Cluster (1)
- Coupled-Cluster (1)
- Covalent inhibitors (1)
- Cross-coupling (1)
- CuAAC 'click' reaction (1)
- Cyclopentadienderivate (1)
- Cyclopentadienylgruppe (1)
- Cyclotrimerisation (1)
- Cyclotrimerization (1)
- Cyclovoltammetrie (1)
- Cymantren (1)
- Cytotoxizität (1)
- C–C coupling (1)
- C–C-Kupplung (1)
- C–H Aktivierung (1)
- C–H activation (1)
- DFT mechanism (1)
- DHAP (1)
- DKH (1)
- DKS-RI (1)
- DKS2-RI (1)
- DNA recognition (1)
- DNA sensing (1)
- DNA-Sensor (1)
- DNA/RNA binding (1)
- DPP III enzyme (1)
- Dendrimer (1)
- Density functional theory (1)
- Diaminosilylenes (1)
- Diboranes (1)
- Diborene (1)
- Diboron(4) Compounds (1)
- Diboryne (1)
- Dichtefunktional (1)
- Dichtefunktionaltheorie (1)
- Diels-Alder-Reaktion (1)
- Diels–Alder reaction (1)
- Dihydroboranes (1)
- Diine (1)
- Dimerization (1)
- Dioncophyllaceae (1)
- Dioncophyllaceae leaves (1)
- Diorganobismut-Spezies (1)
- Dodecaborane (1)
- Drugs (1)
- Duftstoff (1)
- E-H bond activation (1)
- ELF (1)
- Earth-Abundant Metal (1)
- Elektrochemie (1)
- Elektronenspinresonanzspektroskopie (1)
- Ester (1)
- Explosives (1)
- Explosivstoff (1)
- E−X bond activation (1)
- Ferrio-silanole (1)
- Ferrio-silanols (1)
- Festelektrolyt (1)
- Festkörperakkumulator (1)
- Festkörperbatterie (1)
- Festkörperelektrolyt (1)
- Fluorescene (1)
- Fluoreszierender Stoff (1)
- Fluoride (1)
- Fluorides (1)
- Fluorierte Arylboronate (1)
- Fluorierung (1)
- Fluorinated Aryl Boronates (1)
- Fluoro(perfluoroalkyl) phosphoranes (1)
- Frustrated Lewis Pairs (1)
- Furanderivate (1)
- Furylboranes (1)
- Ganglia (rat) (1)
- Gas chromatography (1)
- Germanium (1)
- Glucagon (1)
- Guinea-pig uterus (1)
- HFC-tensor (1)
- HSAB principle (1)
- HT-29 colon carcinoma cells (1)
- Halbsandwich-Komplexe (1)
- Halfsandwich-complexes (1)
- Hauptgruppenelementverbindungen (1)
- Heteroaromaten (1)
- Hexadehydro-Diels-Alder (1)
- Hexahydro-difenidol (1)
- Hexahydro-difenidol analogues (1)
- Hexahydro-procyclidine (1)
- Hexbutinol (1)
- Hexocyclium/sila-hexocyclium derivatives (1)
- Homogene Katalyse (1)
- Homogeneous Catalysis (1)
- Hydroarylation (1)
- Hydrophosphination (1)
- Hydrophosphinierung (1)
- Hyperfeinkopplungstensor (1)
- Hyperfinekopplungskonstante (1)
- Hypervalenz (1)
- Höherkoordination (1)
- Ileum; Atrium (1)
- Iminoborane (1)
- Indole conjugation (1)
- Inhibition (1)
- Insulin (1)
- Inverse Gaschromatographie (1)
- Iridium bis(phosphinite) pincer complexes (1)
- Iridiumkomplexe (1)
- Islets of Langerhans (rat) (1)
- Isoelektronisches Prinzip (1)
- Janus Head Ligand (1)
- Januskopfligand (1)
- K-region (1)
- Kaiser test (1)
- Katalyse (1)
- Kation (1)
- Kidney (perfused (1)
- Komplexe (1)
- Konjugate (1)
- Koordinationschemie (1)
- Koordinationsverbindungen (1)
- Kristallographie (1)
- Kristallstruktur (1)
- Kupfer katalyse (1)
- LCMS- based kinetic studies (1)
- Lambda5-Germanate (1)
- Larvae (1)
- Lewis acid (1)
- Lewis acid/base adducts (1)
- Lewis adducts (1)
- Lewis-Addukt (1)
- Lewis-Azidität (1)
- Lewis-Base Adducts (1)
- Lewis-Säure (1)
- Lewis-base adducts (1)
- Liganddesign (1)
- Liganden (1)
- Ligandendesign (1)
- Lippert–Mataga plot (1)
- Lithium-Ionen Batterie (1)
- Lithium-Ionen-Akkumulator (1)
- Ln-MOFs (1)
- Luminescence (1)
- M2 muscarinic receptors (1)
- M4 receptors (1)
- MOF (1)
- Magnesium (1)
- Mangan (1)
- Manganese (1)
- Manganese Carbonyl ligands (1)
- Mangankomplexe (1)
- McN-A-343 analogs (1)
- Metallcarbonyle (1)
- Metallkomplexe (1)
- Metallkoordination (1)
- Metallo-silanole (1)
- Metallo-silanols (1)
- Metallocene (1)
- Metallocenes (1)
- Metalloradicals (1)
- Metallorganische Chemie (1)
- Metallorganische Verbindungen (1)
- Metallorganisches Netzwerk (1)
- Methoctramine (1)
- Methyllithium (1)
- Molecular Dynamics (1)
- Molybdän (1)
- Molybdäncarbonyle (1)
- Multiple bonding (1)
- Muscarin (1)
- Muscarinic M1 receptors (1)
- Muscarinic M1 receptors; Muscarinic M2 receptors (1)
- Muscarinic M3 receptor subtypes (1)
- Muscarinic M3selective antagonists (1)
- Muscarinic antagonist (1)
- Muscarinic receptor agonists (1)
- Muscarinic receptor antagonists (M 3-selective) (1)
- Muscarinic receptor antagonists (selective) (1)
- Muscarinic receptor subtype (1)
- Muscarinic receptor subtypes; Muscarinic rcceptor agonists (M 1-selective) (1)
- Muscarinie M2 receptors (1)
- Musearinic M4 receptors (1)
- Musearlnie M1 (1)
- Musearlnie aeetyleholine receptor agonists (1)
- Musearlnie aeetyleholine receptor antagonists (1)
- Musearlnie receptor subtypes (1)
- N-Heterocyclic Carbene (1)
- N-Heterocyclic Carbene Adducts (1)
- N-Heterocyclic carbenes (1)
- N-Liganden (1)
- N-functionalization (1)
- N-heterocyclic olefins (1)
- N-heterocyclic silylenes (1)
- N-heterozyklische Carbene (1)
- N-ligands (1)
- N-methylpyridinium pyrene (1)
- NHC Complexes (1)
- NHC-Copper-catalyst (1)
- NHC-Nickel-Catalyst (1)
- NHCs (1)
- NIR OLED (1)
- NMR spectroscopy (1)
- Nanodiamant (1)
- Nanodiamond (1)
- Nanopartikel (1)
- Neuropeptide Hormone (1)
- Neuropeptidhormon (1)
- Nickel (1)
- Nickel ComplexCyclic (1)
- Nickel Complexes (1)
- Nickel-Complexes (1)
- Niedervalente Spezies (1)
- N‐Heterocyclic Carbenes (1)
- OLED (1)
- OLEDs (1)
- Olefin Complexes (1)
- Oligomere (1)
- Optical spectroscopy (1)
- Organoazides (1)
- Organoboron (1)
- Organoboron Compounds (1)
- Organoboron chemistry (1)
- Organometall-Komplexe (1)
- Organometallic chemistry (1)
- Oxidation states (1)
- Oxidationsstufen (1)
- Oxidationszahl (1)
- Oxyphencyclimine (1)
- P-Liganden (1)
- P-ligands (1)
- PAK (1)
- PBP pincer palladium complexes (1)
- Palladium-catalyzed silaboration (1)
- Palladiumkomplexe (1)
- Parameter <Mathematik> (1)
- Parent Piano-Stool Complex (1)
- Particle analytics (1)
- Partikelanalytik (1)
- Peptide (1)
- Perylen (1)
- Perylene (1)
- Pharmacokinetics (1)
- Phosphan (1)
- Phosphane (1)
- Phosphaneligands (1)
- Phosphanliganden (1)
- Phosphatidylinositol metabolism (1)
- Phosphenium (1)
- Phospheniumkomplexe (1)
- Phosphiniden (1)
- Phosphorane (1)
- Phosphorescence (1)
- PhotoCORMs (1)
- Photocatalysis (1)
- Photochemie (1)
- Photochemistry (1)
- Photoelektronenspektroskopie (1)
- Photophysics (1)
- Photosystem II (1)
- Pirenzepine (1)
- Pithed rat (1)
- Platinkomplexe (1)
- Pnictogen reduction (1)
- Polyarylenvinylene (1)
- Polycyclic Aromatic Hydrocarbons (1)
- Polycyclische Aromaten (1)
- Polyiminoboranes (1)
- Polyine (1)
- Polynucleotide (1)
- Polyphenylenvinylenanaloga (1)
- Polyzyklen (1)
- Preconcentration (1)
- Präparative organische Chemie (1)
- Pseudohalogenide (1)
- Pyren (1)
- Pyrene (1)
- Pyridinderivate (1)
- Pyrrinol (1)
- QTAIM (1)
- Quantenchemie (1)
- R factor = 0.018 (1)
- R factor = 0.025 (1)
- RNA recognition (1)
- RU(CO)(3)CL(GLYCINATE) (1)
- Raman probes (1)
- Rat (1)
- Reaction mechanism (1)
- Reaktionsbarrieren (1)
- Reaktionsmechanismus (1)
- Reaktivität (1)
- Rhodacyclopentadiene (1)
- Ring Expansion Reaction (1)
- Ruthenium (1)
- Rutheniumkomplexe (1)
- SARS-CoV-2 (1)
- SPION (1)
- Sandwich-Verbindungen (1)
- Schutzgruppe (1)
- Schwefelverbindungen (1)
- Selen (1)
- Selenium (1)
- Sila-biperiden (1)
- Sila-drug (1)
- Sila-hexocyclium (1)
- Silandiylverbindungen (1)
- Silanol (1)
- Silicate (1)
- Silicium Komplexe (1)
- Siliciumkomplexe (1)
- Siliciumorganische Verbindungen (1)
- Silicon-Boron exchange (1)
- Silizium-Bor Austausch (1)
- Silizium-Bor-Austausch (1)
- Silylenes (1)
- Singlet Oxygen (1)
- Singlett Oxygen (1)
- Singulettsauerstoff (1)
- Sonogashira coupling (1)
- Sonogashira reaction (1)
- Spin density (1)
- Spindichte (1)
- Sternpolymere (1)
- Stickstoffverbindungen (1)
- Sulfat (1)
- Sulfate (1)
- Sulfit (1)
- Sulfite (1)
- Sulfoxide (1)
- Sulfoximin (1)
- Sulfur (1)
- Sulphur (1)
- Superior cervical ganglia (calf) (1)
- Surface modification (1)
- Säure (1)
- T = 173 K (1)
- T = 174 K (1)
- T = 199 K (1)
- T cell (1)
- TD-DFT (1)
- TDDFT (1)
- Tellur (1)
- Tellurium (1)
- Tetrafluorodiborane (1)
- Tin (1)
- Titanium (1)
- Transient absorption (1)
- Transiente Absorption (1)
- Transition Metals (1)
- Transition metal silylene complexes (1)
- Transition metal-free (1)
- Transitionmetal (1)
- Tricarbonylverbindungen (1)
- Trifluormethylphenylgruppe (1)
- Trihexyphenidyl (1)
- Triphyophyllum peltaturn (1)
- Tungsten (1)
- Uranium (1)
- Validierung (1)
- Vas deferens (1)
- Vas deferens (rabbit) (1)
- Venlafaxin (1)
- Verzögerte Fluoreszenz (1)
- Vidcomicroscopy (1)
- Wade’s rules (1)
- Wasserstoffperoxid (1)
- Wirkstoff (1)
- X-ray crystallography (1)
- Zink (1)
- Zweiphotonenabsorption (1)
- Zwitterion (1)
- Zyklisierung (1)
- [3H]-Hexahydro-siladifenidol (1)
- \(\pi\) interactions (1)
- acenes (1)
- acetone (1)
- acetylcholine (1)
- acid secretion (1)
- acid sphingomyelinase (1)
- acid/base adducts (1)
- activated delayes flourescence (1)
- alcohol (1)
- alkali metal (1)
- alkenes (1)
- alkyl halides (1)
- alkylideneborane (1)
- alkyne complexes (1)
- alkynes (1)
- all solid-state battery (1)
- aluminium (1)
- aluminum (1)
- amber light (1)
- amination (1)
- amine borane dehydrocoupling (1)
- amino acids (1)
- amino groups (1)
- aminyl radicals (1)
- anionic carbene (1)
- anionic dimetalloborylene complexes (1)
- anioniccarbene (1)
- anions (1)
- anorganic chemistry (1)
- anti-proliferative effects (1)
- anti-tumor agents (1)
- antiaromaticity (1)
- anticancer activity (1)
- antidepressants (1)
- antihypertensive agents / pharmacology (1)
- antimuscarinics (1)
- aorta, abdominal / drug effects (1)
- aorta, abdominal / physiology (1)
- aorta, abdominal / ultrastructure (1)
- aqueous-solution (1)
- arbenes (1)
- arecoline (1)
- arecoline/analogs & derivatives (1)
- arylmetalate (1)
- aryltricyanoborates (1)
- atropine (1)
- azaborinines (1)
- azaborole (1)
- azadiboretidines (1)
- azido borane (1)
- azobenzenes (1)
- bacteria (1)
- beryllium (1)
- bexarotene (1)
- binary species (1)
- binding (1)
- binding/functional correlations (1)
- bioconjugate (1)
- bioimaging (1)
- bioisosterism (1)
- biolabelling (1)
- bioorganometallic chemistry (1)
- biradicals (1)
- bismuth amides (1)
- blend (1)
- bond Activation (1)
- bond analysis (1)
- bond dissociation energies (1)
- bond formation (1)
- bond polarisation (1)
- bond theory (1)
- bonding analysis (1)
- boracycle (1)
- borafluorenes (1)
- borane (1)
- boraselenone (1)
- borates (1)
- boric acid (1)
- borirane (1)
- borohydrides (1)
- boroles (1)
- boron chains (1)
- boron heterocycles (1)
- boron reagents (1)
- boron tetraiodide (1)
- boron-bound hydrogen (1)
- boron-centred nucleophile (1)
- boron-nitrogen bond (1)
- boronate ester (1)
- boronateesters (1)
- boronium cations (1)
- boryl anion (1)
- borys (1)
- cAAC (1)
- campylobacter-jejuni (1)
- canonicalization (1)
- carbanion (1)
- carben (1)
- carbene (1)
- carbene donor (1)
- carbene-stabilized nickel complexes (1)
- carbocations (1)
- carbon dioxide (1)
- carbon nanomaterials (1)
- carbonmonoxide (1)
- carbonyl (1)
- carmine (1)
- catenation (1)
- cell-penetrating peptides (1)
- chain structures (1)
- chalcogen (1)
- chelates (1)
- chemical identifier (1)
- cheminformatics (1)
- chirality and odour (1)
- chromism (1)
- chromophores (1)
- circular dichrosism (1)
- circularly polarized luminescence (1)
- click CuAAC synthesis (1)
- closo-Borane (1)
- co-gels (1)
- conjugated oligomers (1)
- conjugated polymers (1)
- context-based teaching (1)
- coupling reactions (1)
- critical points (1)
- cross‐coupling (1)
- crystal scructure (1)
- crystal-structure (1)
- crystallographic analyses (1)
- crystallography (1)
- cumulene (1)
- cyclic (alkyl)(amino) carbenes (1)
- cyclic (alkyl)(amino)carbene (1)
- cyclic alkyl(amino)carbene (1)
- cyclic alkyl(amino)carbenes (1)
- cyclization (1)
- cyclization reactions (1)
- cyclooligomerization (1)
- cyclopenten-4-yl cation (1)
- cyclotrimerization (1)
- cymantrene (1)
- cytotoxicity (1)
- data-to-parameter ratio = 14.0. (1)
- data-to-parameter ratio = 14.6 (1)
- data-to-parameter ratio = 20.8 (1)
- data-to-parameter ratio = 22.3 (1)
- data-to-parameter ratio = 23.6. (1)
- decafluoroazobezene (1)
- decarbonylation (1)
- deficient mutant (1)
- dehydrogenaticve borylation (1)
- dendrimer (1)
- dendrimer conjugates (1)
- density functional theory (1)
- density-functional calculations (1)
- derivates (1)
- design (1)
- desymmetrization (1)
- diamines (1)
- diboraindanes (1)
- diborane(6) (1)
- diboron (1)
- diboryne (1)
- dicoordinate borylene (1)
- dicyclidol (1)
- difenidol (1)
- diimidoborane (1)
- diketopiperazines (1)
- dilaboration (1)
- diphosphanes (1)
- dismutations (1)
- donor (1)
- donor-acceptor systems (1)
- donor–acceptor (1)
- drug delivery (1)
- dual fluorescence (1)
- electrochemical fluorination (1)
- electrolytes (1)
- electron donors (1)
- electron storage (1)
- electron-precise diborates (1)
- electronic differentiation (1)
- electrophiles (1)
- elektronische Differenzierung (1)
- enamines (1)
- enantiomers of / Muscarinic receptors (1)
- endothelium, vascular / drug effects (1)
- endothelium, vascular / physiology (1)
- enediyne (1)
- energy transfer (1)
- enthalpy (1)
- entropy (1)
- enyne (1)
- enzyme (1)
- equilibrium (1)
- erovalent diboron compounds (1)
- esters and alcohols (1)
- flame test (1)
- flavour substances (1)
- fluerescence (1)
- fluorescence spectroscopy (1)
- fluorescent probe (1)
- fluorinated ligands (1)
- fluorination (1)
- fluoroarenes (1)
- fluoroborates (1)
- food colorings (1)
- fullerenes (1)
- functionalization (1)
- furan (1)
- fused boracycles (1)
- fused thiazaboroles (1)
- gastric acid/secretion (1)
- gastric/secretion parietal cells (1)
- gem-bisboronates (1)
- germanium (1)
- glandular M3 receptor (1)
- glioblastoma (1)
- group 10 element (1)
- group 13 (1)
- group 8 metals (1)
- half-sandwich complexes (1)
- halides (1)
- halogenation (1)
- halogens (1)
- heavier pnictogens (1)
- heavy metals (1)
- helicenes (1)
- hemilabil (1)
- hemilabile (1)
- heterocyclic carbenes (1)
- heterodinuclear compound (1)
- hexacoordinate (1)
- hexadehydro-Diels-Alder (1)
- hexahydro-difenidol enantiomers (1)
- hexahydrosiladifenidol (1)
- hexakisadducts (1)
- hexakoordinierte (1)
- hexamethonium (1)
- hexamethonium compounds (1)
- high efficiency (1)
- higher-coordination (1)
- homochiral dimer (1)
- human gastric mucosa (1)
- hydrazone (1)
- hydrides (1)
- hydroamination (1)
- hydroarylation (1)
- hydrogen (1)
- hydrogen bonding (1)
- hyperconjugation (1)
- hyperfine coupling constant (1)
- hypervalency (1)
- iClick reactions (1)
- iGC (1)
- imaging (1)
- imide ligands (1)
- iminoboranes (1)
- indomethacin (1)
- insertion (1)
- internalization studies (1)
- intersystem crossing (1)
- intersystem crossing (1)
- intracellular hydrogen-peroxide (1)
- intramolecular Michael addition (1)
- iodine (1)
- isoelectronic analogues (1)
- isomer (1)
- isomerisation (1)
- isomerization (1)
- isomers (1)
- ketenes (1)
- kinetics (1)
- koordination chemistry (1)
- kritische Punkte (1)
- lanthanides (1)
- lead (1)
- lewis acid/base adducts (1)
- lewis superacid (1)
- ligand (1)
- ligand exchange (1)
- light-emitting-diodes (1)
- line notations (1)
- lithium-ion battery (1)
- low-cost photometer (1)
- low-cost spectrometer (1)
- low-valent main-group species (1)
- luminescence crystal structure (1)
- luminescent (1)
- main-group metals (1)
- major depression (1)
- male (1)
- manganese tricarbonyl complexes (1)
- mean σ(C–C) = 0.003 Å (1)
- mean σ(C–C) = 0.004 Å (1)
- mechanism (1)
- metal borylene complexes (1)
- metal caponyls (1)
- metal carbonyl (1)
- metal coordination (1)
- metal-free (1)
- metal-metal interactions (1)
- metal-organic frameworks (1)
- metallaboranes (1)
- metallacycles (1)
- metathesis (1)
- methyl exchange (1)
- methyl viologen (1)
- methylbismuth (1)
- methyllithium (1)
- molecular graphs (1)
- molecular modelling (1)
- molecular properties (1)
- molecular representation (1)
- molecular structures (1)
- molecular-structure (1)
- molecule isomorphism (1)
- molekulare Eigenschaften (1)
- molybdenum (1)
- mononuclear (1)
- multicomponent Ugi-type reaction (1)
- muscarinic antagonists (1)
- muscarinic receptor antagonists (1)
- muscarinic receptor subtype (1)
- muscarinic receptors (1)
- muscarinic/drug effects receptors (1)
- muscarinic/physiology receptors (1)
- muscle contraction (1)
- muscle relaxation (1)
- myoglobin assay (1)
- nanodiamond (1)
- naphthylisoquinoline alkaloids (1)
- naphthyridine (1)
- near-IR chromophores (1)
- nickel complexes (1)
- nitrogen heterocycles (1)
- nitrogen ligands (1)
- nitrogen trichloride (1)
- non-coordinate anionic ligand (1)
- non-radiative decay (1)
- norepinephrine (1)
- nucleic acid (1)
- nucleophile (1)
- nucleophilic addition (1)
- nucleophilic substitution (1)
- o-carborane (1)
- odourants (1)
- oligomerization (1)
- oligomers (1)
- optical materials (1)
- organic and inorganic synthesis (1)
- organic electronics (1)
- organic light-emitting diodes (1)
- organic synthesis (1)
- organoboron (1)
- organocatalytic (1)
- organometal complexes (1)
- organometallic chemistry (1)
- organometallic complexes (1)
- organosilicon (1)
- orthogonal self-assembly (1)
- orylation (1)
- ow-cost photometer (1)
- oxidation (1)
- oxidative stress (1)
- oxime ligation (1)
- oxygen-metabolism (1)
- p-Block Elements (1)
- p-Fluoro-hexahydro-sila-difenidol (1)
- p-block element (1)
- p-fluoro-hexahydro- (1)
- palladium(II) and platinum(II) triazolato complexes (1)
- palladium-catalyzed (1)
- parasympatholytics/pharmacology (1)
- pentakoordinierte (1)
- peptide conjugates (1)
- peptide stapling (1)
- peptides (1)
- perfluoroalkyl (1)
- perfluoroarylation (1)
- pericyclic reaction (1)
- phosphenium (1)
- phosphine ligands (1)
- phosphinidene (1)
- phosphinidenes (1)
- phosphoranes (1)
- phosphorescene spectra (1)
- phosphorus (1)
- phosphorus heterocycles (1)
- photocatalysis (1)
- photocontrol (1)
- photodynamic therapy (1)
- photoelectron spectroscopy (1)
- photoisomerization (1)
- photolysis (1)
- photophysical prosperties (1)
- phthalocyanines (1)
- pincer ligand (1)
- piperazines (1)
- piperazines/pharmacology (1)
- piperidines/pharmacology (1)
- pirenzepine (1)
- pnictogen coupling (1)
- polycyclic aromatic hydrocarbon (1)
- polymer matrix (1)
- polymers (1)
- porous materials (1)
- potassium reagent (1)
- probes (1)
- protecting group (1)
- protein sensing (1)
- pseudohalides (1)
- push-pull stabilization (1)
- push–pull thienylthiazole (1)
- pyrazine (1)
- pyrenes (1)
- pyridinium (1)
- python (1)
- rabbits (1)
- radical coupling (1)
- radical species (1)
- radioligand assay (1)
- rat) (1)
- rats (1)
- reaction mechanisms (1)
- reactive intermediates (1)
- rearrangement (1)
- rearrangements (1)
- receptors (1)
- redox chemistry (1)
- redox processes (1)
- redox reactions (1)
- redox-active ligands (1)
- reduction (1)
- reductive coupling (1)
- regulatory T cells (1)
- relativistic (1)
- relativistisch (1)
- ring opening reactions (1)
- ring strain (1)
- ring-expansion reactions (1)
- room temperature phosphorescence (1)
- room-temperature phosphorescence (RTP) (1)
- ruthenium (1)
- s-block metals (1)
- salt metathesis (1)
- selectivity (1)
- selenolysis (1)
- sensors (1)
- shaping of porosity (1)
- sigma boranes (1)
- sila-drugs (1)
- silaboration (1)
- silicates (1)
- silicon complexes (1)
- silicon-boron exchange (1)
- silver (1)
- silyl selenides (1)
- silyl sulfides (1)
- silylenes (1)
- singe crystal (1)
- single photon (1)
- small HOMO-LUMO gap (1)
- software library (1)
- solid state (1)
- solid-state NMR (1)
- solid-state electrolyte (1)
- solid-state sturcture (1)
- solvatochromism (1)
- spectroscopy (1)
- sphingolipids (1)
- spin distribution (1)
- spiroborates (1)
- stereoselective (1)
- stereoselective interaction (1)
- steric effects (1)
- stibinidenes (1)
- stomach (1)
- strained molecules (1)
- strategy (1)
- structural analysis (1)
- structure/ affinity relationships (1)
- subtypes of (1)
- sulfoimines (1)
- sulfur (1)
- supramolecular assembly (1)
- supramolecular chemistry (1)
- synchrotron radiation (1)
- synthesis (1)
- synthesis design (1)
- synthesis silicon (1)
- synthetic methodology (1)
- temperature dependence of reaction rate (1)
- terminal alkynes (1)
- tetracoordinated boron (1)
- tetramers (1)
- tetrametallaborides (1)
- tetraorganoborate salt (1)
- theoretical calculations (1)
- thermal rearrangement (1)
- thermal treatment (1)
- thermodynamics (1)
- thiolysis (1)
- thiophene (1)
- thiosemicarbazone (1)
- three-coordinate borane (1)
- threecoordinate boron (1)
- tin (1)
- transfer hydrogenation (1)
- transient absorption (1)
- transition metal (1)
- transition metal complexes (1)
- transition metal-free (1)
- transition metals (1)
- triarylamine (1)
- triarylboranes (1)
- triboranes (1)
- trimetallaborides (1)
- triple bonds (1)
- triplet (1)
- trivalent boron (1)
- tropocoronands (1)
- tungsten (1)
- ultrafast Raman loss spectroscopy (1)
- van 't Hoff plot (1)
- van‘t Hoff rule (1)
- venlafaxine (1)
- viologens (1)
- wR factor = 0.038 (1)
- wR factor = 0.052 (1)
- wR factor = 0.069 (1)
- weak intermolecular coordination (1)
- ylides (1)
- zwitterionische (1)
- Übergangselemente (1)
- Übergangsmetallkomplex (1)
- Übergangsmetallverbindungen (1)
- α-aminoboronates (1)
- π aromaticity (1)
- π-extension (1)
Institute
- Institut für Anorganische Chemie (352) (remove)
Sonstige beteiligte Institutionen
- Fraunhofer Insitut für Silicatforschung ISC (1)
- Fraunhofer-Institut für Chemische Technologie (ICT) (1)
- Institut Ruđer Bošković, Zagreb, Croatia (1)
- Institut für Organische Chemie, RWTH Aachen (1)
- Institute for Sustainable Chemistry & Catalysis with Boron (1)
- Institute of Transformative Bio-Molecules, Nagoya University, Nagoya, Japan (1)
- Paul Scherrer Institut (1)
- The Chinese University of Hong Kong (1)
- The University of Sussex (1)
- Université de Bordeaux, Bordeaux, France (1)
Silylation of cellulose
(1977)
Ethane-l:2-diol and propane-l:3-diol reaet with 1: 1:3:3-tetramethyl-l:3-dichlorodisiloxane forming the corresponding rings. However, no ring compounds could be traced tbrough the reaction between butane-l :4-diol, glycerol and the dichlorodisiloxane respectively, where only polymeric compounds are formed. The silylation products of the di- and trihydroxy alcohols, as model compounds, has confirmed that the ring formation during silylation of cellulose with dichlorodisiloxane is uncertain.
15 new C/Si-analogue pairs (C-compounds and sila- or disila-substituted derivatives, respectively), which are structurally related to nifedipine, have been synthesized. These and some further C/Si-pairs have been investigated comparatively with respect to their physicochemical and pharmacological properties. Using reversed-phase thin-layer chromatography it was shown that both the sila- and disila-analogues are more Iipophilic than the corresponding C-compounds. With respect to the in vitra spasmolytic potencies the Si-compounds show approximately similar structure-activity relationships to their carba-analogues. However, in some cases marked differences in in vivo effects (cardiovascular and antihypertensive activity) could be demonstrated.
The crystal structures of the (R)-enantiomer (2b) and the racemate (1 b) of (cyclohexyl)phenyl[2- (pyrrolidin-1-yl)ethyl]silanol (sila--procyclidine) have been determined by X -ray structural analysis. The absolute configuration of (2b) was established. (2b) crystallizes in the orthorhombic space group P2\(_1\)2\(_1\)2\(_1\), with a = 15.221 (1 ), b = 17.967(1 ), c = 6.463(1) A, and Z = 4. (1 b) crystallizes in the monoclinic space group P2\(_1\)/c, with a = 6.441 (1 ), b = 17.1 82(7), c = 16.707(4) A, ß = 1 03.86(2r, and Z = 4. The structures were refined to respective R factors of 0.044 and 0.058. The molecular conformation of sila-procyclidine is identical in the two different structures. lntermolecular 0-H • • • N hydrogen bonding is observed in both crystallattices.ln (1 b) (R)- and (S)-configurated molecules form centrosymmetric dimers, in (2b) the (R)-configurated molecules are linked into infinite chains parallel to the c axis. The (R)-configurated sila--procyclidine (2b) has higher affinity for ileal and atrial muscarinic receptors of the guinea pig than the (S)-configurated enantiomer (3b).
Crystals of the R, S diastereoisomer of [Cp(CO)\(_2\)-FeSiCH\(_3\)F]\(_2\)O are monoclinic, space group ndc (No. 14), with a = 846.0(3) [836.4(1»), b = 768.0(3) [757.1(1»), c = 1548.5(4) [1522.3(2)] pm, {3 = 97.34(3t [97.47(3t] at 300 K [120 K] with Z = 2. Even at 120 K the Si-O-Si fragment is found to be strictly linear due to crystallographically imposed symmetry. To explain the unusual electron distribution derived from the X-ray data collected, several types of possible disorders are discussed, none of which leads to a satisfying explanation. Retaining the Ci symmetry (linear Si-O-Si fragment in the final model) the important bond lengths are Fe-Si 226.7(1) [226.5(1)] pm, Si-F 160.9(2) [161.8(2)] pm, Si-O 160.3(1) [161.1(1)] pm, Si-C 185.0(3) [185.6(3)] pm. The electronic features of this compound were probed via molecular orbital calculations of the extended Hiickel type. It was found that the lone pairs on the siloxane oxygen were tipped away from cylindrical symmetry. The tipping was directed toward the fluorine substituents on the silicon atoms and away from the CpFe(CO)\(_2\) units. A pertubational approach was utilized to rationalize this effect.
Enantioselective reduction of acetyldimethylphenylsilane by Trigonopsis variabilis (DSM 70714)
(1987)
Growing and resting cells of the yeast Trigonapsis variabilis (DSM 70714) can be used for the enantioselective reduction of the organosilicon compound acetyldimethylphenylsilane (J) to give optically active (R)-(1-hydroxyethyl)dimethylphenylsilane [(R)-2] in good yields. The enantiomeric purity of the isolated product was determined tobe 62-86% ee depending on the substrate concentration used. Both substrate and product caused an inhibition of the reaction at concentrations higher than 0.35 and 0.5 g/1, respectively. Besides, higher substrate and product concentrations led to increased formation of the by-product 1,1,3,3-tetramethyl-1,3-diphenyldisiloxane. Considering the limiting substrate and product concentrations, it was possible to use the same biomass at least 5 times without significant loss of enzyme activity. 3-Methyl-3-phenyl-2-butanone (5) and acetyldimethylphenylgermane (7), which represent carbon and germanium analogues of 1, were also found to be accepted as substrates by Trigonapsis variabilis (DSM 70714). The reduction rates of the silicon {1) and germanium compound {7) were much higher than the transformation rate of the corresponding carbon analogue 5.
Thirty strains of microorganisms (bacteria, yeasts, fungi and green algae) were tested as resting free cells for their ability to transform acetyldimethylphenylsilane (1) enantioselectively into (R)-(1-hydroxyethyl) dimethylphenylsilane [(R)-2]. The biotransformations were monitared by GC (packed OV-17 column), and the enantiomeric purities of the products isolated were determined by HPLC (cellulose triacetate column, UV detection). All microorganisms tested were found to reduce 1 enantioselectively to give (R)-2. Under the test conditions used, the yeast Trigonapsis variabilis (DSM 70714) was found to 1 exhibif the highest specific activity (1.5 mg product x g cell wet mass\(^{-1}\) x min\(^{-1}\) ), whereas the highest enantioselectivities were observed for the bacteria Acinetobacter ca lcoaceticus (ATCC 31012) (>95% ee), Brevfbacterium species (ATCC 21860) (90% ee) and Corynebacterium dioxydans (ATCC 21766) (>95% ee), the yeast Candida humico la (OSM 70067) (90% ee), the fungus Cunninghame lla e legans (ATCC 26269) (94% ee), as well as the cyanobacterium Synechococcus leopoliensis (94% ee).· From the green algae tested, Chlamydomonas reinhardii showed the highest.enantioselectivity (85% ee).
The present study was designed to further charaeterize the presynaptie musearlnie M\(_1\)-reeeptor responsible for the inhibition of neuragenie eontraetions in the isolated rabbit vas deferens. Eleetrically induced twiteh eontraetions of this preparation were inhibited by the M\(_1\)-agonist, MeN-A-343, and by some of its analogs: 4-ehloro-phenyl derivative> MeN-A-343 > trans-olefinie analog> cis-olefinie analog. The same rank order of potency was observed for these agonists to raise the blood pressure of pithed rats by stimulation of M\(_1\)-receptors in sympathetie ganglia. A highly signifieant eorrelation was found between the antimusearinie potencies of atropine, pirenzepine and a series of 9 antagonists strueturally related to the ganglionie M\(_{1\beta}\)-receptor selective compounds, hexocyclium and hexahydro-difenidol, to antagonize the MeN-A-343-indueed inhibition of twitch eontraetions in rabbit vas deferens or the musearine-indueed depolarization in rat isolated superior eerVieal ganglia. It is suggested that the presynaptie musearlnie receptor that mediates inhibition of neuragenie contraetions in rabbit vas deferens is of the ganglionic M\(_{1\beta}\)-type.
The synthesis of the potent and highly selective silicon-containing antimuscarinic agent o-methoxysila- hexocyclium methyl sulfate and its corresponding tertiary amine (isolated as the dihydrochloride) is described. The quarternary compound is an omethoxy derivative of sila-hexocyclium methyl sulfate, which represents one of the tools currently used in experimental pharmacology for the subclassification of muscarinic receptors. The omethoxy derivative, the pharmacological profile of which differs substantially from tbat of the nonmethoxy compound, is also recommended as a tool for the investigation of muscarinic receptor heterogeneity.
l In an attempt to assess the structural requirements for the musearlnie receptor selectivity of hexahydro-diphenidol (hexahydro-difenidol) and hexahydro-sila-diphenidol (hexahydro-sila-difenidol), a serles of structurally related C/Si pairs were investigated, along with atropine, pirenzepine and methoctramine, for their binding affinities in NB-OK 1 cells as well as in rat heart and pancreas. 2 The action of these antagonists at musearlnie receptors mediating negative inotropic responses in guinea-pig atrla and ileal contractions has also been assessed. 3 Antagonist binding data indicated that NB-OK 1 cells (M\(_1\) type) as weil as rat heart (cardiac type) and pancreas (glandularjsmooth muscle type) possess different muscarinic receptor subtypes. 4 A highly significant correlation was found between the binding affinities of the antagonists to muscarinic receptors in rat heart and pancreas, respectively, and the affinities to muscarinic receptors in guinea-pig atria and ileum. This implies that the musearlnie binding sites in rat heart and the receptors in guinea-pig atrla are essentially similar, but different from those in pancreas and ileum. 5 The antimuscarinic potency of hexahydro-diphenidol and hexahydro-sila-diphenidol at the three subtypes was inftuenced differently by structural modifications (e.g. quaternization). Different selectivity profiles for the antagonists were obtained, which makes these compounds useful tools to investigate further muscarinic receptor heterogeneity. lndeed, the tertiary analogues hexahydrodiphenidol (HHD) and hexahydro-sila-diphenidol (HHSiD) bad an M\(_1\) = glandularjsmooth muscle > cardiac selectivity profile, whereas the quaternary analogues HHD methiodide and HHSiD methiodide were M\(_1\) preferring (M\(_1\) > glandularjsmooth muscle, cardiac).
In an attempt to assess the structural requirements of hexahydro-sila-difenidol for potency and selectivity, a series of analogues modified in the amino group and the phenyl ring were investigated for their affinity to muscarinic M1- (rabbit vas deferens), Mr (guinea-pig atria) and Mr (guinea-pig ileum) receptors. All compounds were competitive antagonists in the three tissues. Their affinities to the three muscarinic receptor subtypes differed by more than two orders of magnitude and the observed receptor selectivities were not associated with high affinity. The pyrrolidino and hexamethyleneimino analogues, compounds substituted in the phenylring with a methoxy group or a chlorine atom as weil as p-fluoro-hexahydro-difenidol displayed the same affinity profile as the parent compound, hexahydro-sila-difenidol: M1 = M3 > M2 • A different selectivity patternwas observed for p-fluoro-hexahydro-sila-difenidol: M3 > M1 > M2 • This compound exhibited its highest affinity for M3-receptors in guinea-pig ileum (pA 2 = 7.84), intermediate affinity for M1-receptors in rabbit vas deferens (pA 2 = 6.68) and lowest affinity for the Mrreceptors in guinea-pig atria (pA 2 = 6.01). This receptor selectivity profile of p-fluoro-hexahydro-sila-difenidol was confirmed in ganglia (M1), atria (M2 ) and ileum (M 3 ) of the rat. Furthermore, dose ratios obtained with either pirenzepine (Mt) or hexahydrosila- difenidol (M2 and M3) and the p-fluoro analogue used in combination suggested that the antagonism was additive, implying mutual competition with a single population of muscarinic receptor subtypes. These results indicate that p-fluoro-hexahydro-sila-difenidol represents a valuable tool for characterization of muscarinic receptor subtypes.
Five different musearlnie receptor subtypes ean be distinguished by the differenees in their amino aeid sequence, the eoupled signal transduetion system, pharmaeologieal binding properties and aetivation of ionie fluxes. The present study served to eharaeterize the binding profile of musearlnie receptors in human eolon eareinoma eells (HT-29) using seleetive musearlnie antagonists. The affinities of the compounds were eompared with their poteney to inhibit cholinergieally-aetivated phosphoinositide metabolism. Pirenzepine displaced [\(^3\)H]N-methyl-scopolamine binding and inhibited inositolphosphate (IP) release with potencies typieal of those of non-M\(_1\) receptors. The M\(_3\) subtype-selective antagonists sila-hexocyelium and hexahydro-sila-difenidol bad high affinity to the musearlnie reeeptors in HT-29 cells (K0 = 3.1 nM and 27 nM, respectively) and inhibited IP release at nanomolar concentrations. The M\(_2\) receptor antagonists, AF-DX 116 and methoctramine, had low antimusearinic poteneies. Our results demonstrate that HT-29 human colon earcinoma cells contain an apparently pure population of M\(_3\) receptors. These cells could serve as a model system for further investigations coneerning regulatory and signal transduction mechanisms associated with glandular muscarinic M\(_3\) receptors.
(R)-1,1-Dimethyl-1-sila-cyclohexan-2-ol [(R)-2] was prepared by enantioselective microbial reduction of 1,1-dimethyl-1-sila-cyclohexan-2-one (1) with growing cells of the yeast Kloeckera corticis (ATCC 20109). At a substrate concentration of 0.5 g/1 (temperature 27° C, incubation time 16 h), (R}-2 was obtained on a preparative scale in 60% yield and with an enantiomeric purity of 92% ee. Repeated recrystallization of the biotransformation product from n-hexane raised the enantiomeric purity to 99% ee.
The goals of the present study were: (1) to investigate thc binding properlies oi (R)- and (S)-procyclidine and two aehiral derivatives of muscarinic M\(_1\)• M\(_2\) and M\(_4\) receptor subtypes and (2) to identify the interaetions which allow these receptors to diseriminate between the two stereoisomers. (R)-Procyclidine showed a higher affinity for human neuroblastoma NB-OK 1 muscarinie M\(_1\) and rat striatum musearinie M\(_4\) receptors. a~ compared to rat cardiac M\(_2\) receptors. (S)-Procyclidine had a 130-iold lower affinity than (R)-procyclidine for M\(_1\) and M\(_4\) receptors. and a 40-fold lower affinity for M\(_2\) receptors. Pyrrinol. the aehiral diphenyl derivative with the eyclohexyl g.roup of (S}-procyclidine replaeed by a phenyl group, has an eight-fold lower affinity for M\(_1\) and M\(_4\) receptors. as eompared to (R)-procyclidine, and a three-fold lower affinity for M\(_2\) receptors. Hexahydro-procyclidine. the eorresponding achiral dicyclohexyl compound, had a 10- to 20-fold lower affinity than (R)-procyclidine for the three reeeptors. The inerease in binding free energy, which is observed when the phenyl and eyclohexyl groups of procyelidine are separately replaeed by cyclohexyJ and phenyl groups, respectively. was additive in the ease of M\(_1\)• M\(_2\) and M\(_4\) receptcrs. This indicates that the musearinic reeeptor s!ereoseleetivity was based on the eoexistence of two binding sites, one preferring a phenylrather than eyclohexyl group and the seeond preferring a cyclohexyl rather than a phenyl group. In addition. there were aiso binding sites for the hydroxy moiety and the protonated amino group of the ligands. The greater affinity and stereoselectivity of M\(_1\) and M\(_4\) muscarinic receptors for (R)-procyelidine reflected the better fit of the eyclohexyl group of (R)-procyclidine to the subsite of M\(_1\) and M\(_4\) as compared to M\(_2\) receptors.
The present study served to investigate the ability of seven selective muscarinic antagonists to inhibit carbachol-induced drinking in the rat. The muscarinic antagonists were given by intracerebroventricular (i.c.v.) injection 1 min before the i.c.v. injection of carbachol (1 \(\mu\)g/rat). The M\(_2\) antagonist, methoctramine, was inactive up to 80.3 nmol/rat. The M\(_3\) antagonist, p-fluoro-hexahydro-sila-difenidol, elicited a modest (42%) but statistically significant inhibition of drinking only at 80 nmol/rat. On the other band, the selective M\(_1\) antagonists, (R)-trihexyphenidyl, o-methoxy-sila-hexocyclium and pirenzepine, produced a marked and dose-dependent inhibition of carbachol-induced drinking, their 1050 values being 0.51. 7.36 and 9.31 nmoljrat. Also the M\(_1\)/M\(_3\) antagonists, 4-diphenylacetoxy-Nmethylpiperidine methiodide and hexahydro-sila-difen.idol, were potent inhibitors of carbachol-induced drinking, their ID\(_50\) values (0.28 and 11.09 nmoljrat) being related to their pA\(_2\) values for M1 receptors in rabbi t vas deferens. These data suggest that carbachol-induced drinking may be mediated by activation of muscarinic M\(_1\) receptors.
Novel pharmacological profile of muscarinic receptors mediating contraction of the guinea-pig uterus
(1990)
The present study was designed to further characterize the muscarinic receptors mediating contraction of the guinea-pig uterus. The affinities of various selective muscarinic antagonists were determined and compared with those obtained at M\(_1\) (rabbit vas deferens), M\(_2\) (guinea-pig atria) and M\(_3\) receptors (guinea-pig ileum). The contractile responses of uterine smooth muscle from immature guinea-pigs to carbachol (pD\(_2\) = 5.73) were competitively antagonized by pirenzepine (pA\(_2\) = 7.04), AF-DX 116 (11-[[2-[(diethylamino)methyl]-1-piperidinyl] acetyl]- 5,11-dihydro-6H -pyrido[2,3-b][1 ,4]benzo. diazepin-6-one) (pA\(_2\) = 6.96), himbacine (pA\(_2\) = 7.92), methoctramine (pA\(_2\) = 7.52), 4-DAMP (4-diphenylacetoxy- N-methylpiperidine methiodide) (pA\(_2\) = 8.87) and sila-hexocyclium (pA\(_2\) = 8.81). A comparison of affinity values indicates that the muscarinic receptors present in guinea-pig uterus display a novel pharmacological profile which is not consistent with the presence of either an M\(_1\), M\(_2\) or M\(_3\) receptor. The affinities determined for the different antagonists rather showed a close similarity to those obtained at muscarinic receptors present in rat striatum and NG108-15 cells which are considered pharmacological equivalents (M\(_4\) receptors) of the m4 gene product. We thus hypothesize that the guinea-pig isolated uterus preparation may serve as a simple functional assay system to study the pharmacology of M\(_4\) receptors.
Cholinergie agents arepotent modulators of insulin release that aet via musearinie reeeptors. We now investigated the muscarinic receptor subtype present in rat panereatic islets in binding and funetional studies. Binding of 5 nM [ \(^3\)H]N-methylscopolamine ([\(^3\)H]NMS) was half maximal at 30 min. At 60 min, the maximal total bindingwas 1.29% and the non-specifie binding (presence of 100 ,uM atropine) was 0.18% of the total radioaetivity per 10 f.'g islet protein. Unlabelled atropine inhibited [\(^3\)H]NMS binding with an IC50 of ca. 30 nM. The rank order of antagonist high-affinity binding was atropine > sila-hexocyelium methyl sulfate (SiHC; M\(_1\) > M\(_3\) > M\(_2\) ) > pirenzepine (M\(_1\)> M\(_2\) = M\(_3\) ) = methoctramine (M\(_2\) > M\(_1\) > M\(_3\) ). The high-affinity K\(_d\)s were 8.5, 56, 1300 and 1300 nM, respectively. The high affinity Kd of the muscarinie receptor agonist, arecaidine propargyl ester (APE), was 8.1 nM. The EC\(_{50}\) for the biologieal effects of APE on insulin and glucagon secretion was 3.2 and 2.3 nM. The rank order for the high-affinity biological effects of antagonists (inhibition of APE-mediated insulin/ glucagon release) was almost the same as for binding. The data indicate that rat pancreatie islets contain neither an M\(_1\) subtype (high-affinity for pirenzepine) nor an M\(_2\) subtype (high-affinity for methoctramine) receptor. However, the data evidence an M\(_3\) receptor subtype, since SiHC in the absence of the M\(_1\) receptor subtype shows a relatively high affinity to the receptors in rat panereatic islets.
1 Tbc affinities of the (R)- and (S)-enantiomers of hexahydro-difenidol (1) and its acetylenie analogues hexbutinol (2), hexbutinol methiodide (3) and p-fluoro-hexbutinol (4) (stereochemieal purity > 99.8%) for musearlnie receptors in rabbit vas deferens (M1), guinea-pig atria (M2) and guinea-pig ileum (M3) were measured by dose-ratio experiments. 2 The (R)-enantiomers consistently showed higher aßinities than the (S)-isomers. The stereosclectivity ratios [(R)/(S)] wcrc greatest with thc enantiomers of 1 (vas deferens: 550; ilcum: 191; atria: 17) and least with thosc ofthc p-Fluoro-analogue 4 (vas defercns: 34; ileum: 8.5; atria: 1.7). 3 The enantiomerie potency ratios for compounds 1-4 were highest in rabbit vas deferens, intermediate in guinea-pig ileum and much less in guinea-pig atria. Thus, these ratios may serve as a predietor of muscarinic receptor subtype identity. 4 (S)-p-Fluoro-hexbutinol [(S)-4] showed a novel receptor selectivity profile with preference for M\(_3\) receptors: M\(_3\) > M\(_2\) \(\geq\) M\(_1\)• 5 These results do not conform to Pfeiffer's rule that aetivity differences between enantiomers are greater with more potent compounds.
Pharmacokinetic properties of the antimuscarinic drug [\(^3\)H]-hexahydro-sila-difenidol in the rat
(1990)
The pharmacokinetics of tritiated hexahydrosila- difenidol ([\(^3\)H]-HHSiD) were examined in rats. Furthermore, the distribution of radioactivity was studied by means of whole body autoradiography. After i. v. administration of 2.9 mg/kg HHSiD plus [\(^3\)H]-HHSiD to anaesthetized rats bearing a catheter implanted in the ductus choledochus and receiving a mannitol infusion, HHSiD was rapidly distributed and metabolized. Only 5% ofthe radioactivity was recovered in blood after 23 s and 0.4% after 2.5 h. 64% of the plasma radioactivity could be extracted with hexane from the samples taken 23 s after administration. 52% of the radioactivity was eliminated within 2.5 h, 13% by urinary and 39% by biliary excretion. Following oral administration of 8.6 mg/kg HHSiD plus [\(^3\)H]-HHSiD there was an absorption of approximately one fourth of the administered radioactivity within 4 h. By means of whole body autoradiography (i. v. injection) as well as by tissue distribution measurement the highest Ievels of radioactivity were found in bile, urine, lung, kidney, adrenals, liver and .pancreas. Thus, after i. v. administration to rats HHSiD is rather quickly distributed, metabolized and excreted. This explains its low antimuscarinic potency in vivo.
Five subtypes of muscarinic receptors have been distinguished by pharmacological and molecular biological methods. This report characterizes the muscarinic subtype present in human gastric mucosa by radioligand binding studies. The receptor density was 27 ± 6 fmol/mg protein and the tritiated ligand N-methylscopolamine had an affinity of (Kn) 0.39 ± 0.08 nM (n = 11). The M1 receptor selective antagonist pirenzepine and the M2 receptor selective ligand AF-DX 116 had low affinities of 148 ± 32 nM (n = 13) and 4043 ± 1011 nM (n = 3) K n , respectively. The glandular M3 antagonists hexahydrosiladifenidol and silahexocyclium had high affinities ofKn 78 ± 23 nM (n = 5) and 5.6 ± 1.8 nM (n = 3). The agonist carbachol interacted with a single low-affinity site and binding was insensitive to modulation by guanine nucleotides. Antagonist and agonist binding studies thus showed an affinity profile typical of M3 receptors of the glandular type.
Muscarinic receptors mediating acid secretion in isolated rat gastric parietal cells are of M3 type
(1990)
Five subtypes of muscarinic receptors have been identified by pharmacological and molecular biological methods. The muscarinic receptor subtype mediating acid secretion at the level of the parietal cell was unknown. Therefore, this study was performed to characterize muscarinic receptors on rat gastric parietal cells using the 3 subtype-selective antagonists hexahydrosiladifenidol and silahexocyclium, which have high affinity for glandular M3 subtypes, and AF-DX 116, which has high affinity to cardiac M2 receptors. The affinity of these antagonists was determined by radioligand binding experiments. In addition, their inhibitory potency on carbachol-stimulated inositol phosphate production was investigated. Inhibition of carbachol-stimulated aminopyrine uptake was used as an indirect measure of proton production. Both M3 antagonists, hexahydrosiladifenidol and silahexocyclium, had nanomolar affinities for parietal cell muscarinic receptors and potently antagonized inositol phosphate production with nanomolar Ki values. Silahexocyclium similarly antagonized aminopyrine accumulation while hexahydrosiladifenidol behaved as a noncompetitive antagonist. AF-DX 116 was a low-affinity ligand and a weak competitive antagonist at parietal-cell muscarinic receptors. It was concluded that muscarinic M3 receptors mediate acid secretion probably by activation of the phosphoinositide second messenger system in rat gastric parietal cells.
Pseudopotentials and valence basis sets to be used in calculations for organometallic compounds of zinc and magnesium have been tested in calculations for the M(CH\(_3\))\(_n\) (M = Zn, Mg; n = 1,2) molecules. Valence correlation effects are treated at the SDCI and CEPA levels. The capability of a polarization potential on zinc to account for the valence shell contracting effect of core valence correlation is studied. Properties considered are geometries, force constants, Mulliken populations, ionization potentials, atomization, and binding energies. Differences in bonding between the two dimethyl compounds are discussed.
A method was developed to detennine the affinities of antimuscarinic drugs at M\(_1\) receptors. [\(^3\)H](±)-Telenzepine served as radioligand in crude preparations of calf superior cervical ganglia and showed high affinity for a single receptor population. consisting of M1 receptors (K\(_D\) = 1.12 nM). Kinetic experiments showed monophasic association (k\(_1\) =0.017 min\(^{-1}\) nM\(^{-1}\) ) and dissociation (k\(_1\) = 0.017 min\(^{-1}\) ) kinetics, the half-life of dissociation being 41 min at 37°C. The kinetie K\(_D\) value amounted to 1.00 nM. M\(_1\) affinities for pirenzepine, methoctramine. hexahydro-sila-difenidol and p-fluoro-hexahydro-sila-difenidol detennined in competition experiments were similar to those found in functional studies with MI receptors in rabbit isolated vas deferens. The binding assay was used to deterriline the affinities of the (R) and (S) enantiomers of tertiary (trihexyphenidyl, hexahydro-difenidol. hexbutinol, p-fluoro-hexbutinol) and quatemary musearlnie antagonists (trihexyphenidyl methiodide. hexbutinol methiodide). Comparison of results obtained with the rabbit vas deferens suggested that the ionic environment may influence the affinities.
(SiR,CR)- and (SiS,CR)-t-butyl(l-hydroxyethyl)methylphenylsilane [(SiR,CR)-2 and (SiS,CR)-3] have been prepared by (R)-selective microbial rcduction of racemic acetyl(t-butyl)methylphenylsilane (rac-1) using resting free cells of the yeast Trigonopsis variabilis (DSM 70714) or the bacterium Corynebacterium dioxydans (ATCC 21766). The biotransfonnations were carried out on a 10 g scale. Afterseparation by column chromatography on silica gel, the optically active diastereomers (SiR,CR)-2 and (SiS,CR)-3 produccd by T. variabilis were obtained in good yields [74% ((SiR,CR)-2). 78% ((SiS,CR)-3)]. The products obtained from the reduction with C. dioxydans were isolated in significantly lower yields [20% ((SiR,CR)-2), 20% ((SiS,CR)-3)]; reaction conditions not optimized). Both bioconversions gave products with high enantiomeric purities (T. variabilis: 91% ee ((SiR,CR)-2), 96% ee ((SiS,CR)-3); C. dioxydons: ~ 991 ee ((SiR,CR)-l), ~ 99% ee ((SiS,CR)-3)). To throw light on the stereochemical aspects of these biotransfonnations, an X-ray diffraction study was carried out on the 3,5-dinitrobenzoate of rac-(SiR,CS/SiS,CR)-3. In addition, 1H NMR spectroscopic stereochemical correlation studies were performed with the (S)-MTPA esters derived from (SiR,CR)-l, (SiS,CR)-3, rac-(SiR,CRjSiS,CS)-2 and rac-(SiR,CSjSiS,CR)-3 [rac-(SiR,CR/ SiS,CS)-2 and rac-(SiR,CS/SiS,CR)-3 were obtained by reduction of rac-1 with LiAIH\(_4\) in diethylether, followed by chromatographic separation of the diastereomers on silica gel]. These stereochemical studies allowed assignment of the absolute configurations and enantiomeric purities of the biotransformation products.
A variety of muscarinic antagonists are currently used as tools to pharmacologically subclassify muscarinic receptors into M\(_1\), M\(_2\) and M\(_3\) subtypes. ln the present study I we have determined the affinity proflies of several of these antagonists at five cloned human muscarinic receptors (m1-m5) stably expressed in Chinesehamster ovary cells (CHO-K1). At all five receptorsl the (R)-enantiomers of trihexyphenidyl and hexbutinol displayed considerably higher affinities (up to 525-fold) than their corresponding (S)-isomers. The stereoselectivity ratios [inhibition constant( S)/inhibition constant(R)] for both pairs of enantiomers were lowest at m2 receptors, suggesting that less stringent configurational demands are made by this receptor subtype. The "M\(_1\)-selective" antagonist (R)-trihexyphenidyl displayed high affinities for m1 and m4 receptors. The "M\(_2\)-selective" antagonists himbacinel (±}-5, 11-dihydro-11-1[(2-[(dipropylamino)methyl]-1- piperidinyllethyl)amino]carbonyii-6H-pyrido(213-b)(1 ~4)benzodiazepine- 6-one (AF-DX 384)1 11-(14-[4-(diethylamino)butyl)-1-piperidinyll acetyl)-5~ 11-dihydro-6H-pyrido(2~3-b) (1~4)benzodiazepine-6-one (AQ-RA 741) and (+K11-(12-[(diethylamino)methyl]-1-piperidinyll acetyl)-5~ 11-di-hydro-6H-pyrido(2~3-b)(1,4)benzodiazepine-6-one (AF-OX 250; the (+)-enantiomer of AF-DX 116] exhibited high affinities for m2 and m41 intermediate affinities for m1 and m3 and low affinities for m5 receptors. This selectivity profile was most prominent for AQ-RA 7 41 I which displayed 195- and 129-fold higher affinities for m2 and m4 receptors than for mS receptors. The "M\(_3\)-selective" antagonist (±)-p-fluoro-hexahydro-sila-difenidol hydrochloride (pFHHsiD) exhibited high affinity for m1 I m3 and m4 receptors. 4-diphenylacetoxy-N-methylpiperidine methiodide (4-DAMP) bound with up to 7 -fold higher affinities to m1 I m31 m4 and m5 receptors than to m2 receptors. Although none of the tested antagonists showed more than 2-fold selectivity for one subtype over all other subtypes, each receptor displayed a unique antagonist binding profile.
Hexahydro-sila-difenidoJ and eight analogues behaved as simple cumpetitive inhibitors of eHJN·methyl·scopoJamine binding to homogenates frorn human neuroblastoma NB-OK 1 cells (M\(_1\) sites), rat heart (M\(_2\) sites), rat pancreas (M\(_3\) sites), and rat striatum 'B' sites (M\(_4\) sites). Pyrrolidino- and hexamethyleneimino analogues showed the same sekctivity profile as the parent compound. Hexahydro-sila-difenidol methiodide and the methiodide of p-fluoro-hexahydro·sila-difenidol had a fügher affinity but a lower selectivity than the tertiary amines. Compounds containing a p·methoxy, p-chJoro or p-fluoro substituent in the phenyl ring of hexahydro-sila-difenidol showed a qualitative)y similar selectivity profile as the parent compound (i.e., M\(_1\)= M\(_3\) = M\(_4\) >M\(_2\) ), but up to 16-fold lower affinities. o-Methoxy-hexahydro-sila-difenidol has a lower affinity than hexahydro-sila-difeni.:!o! at the four binding sites. lts selectivity profile (M\(_4\) > M\(_1\), M\(_3\) > M\(_2\) ) was different from hexahydro-sila-difenidol. Replacement of the centrat silicon atom of hexahydro-sila-difenidol, p-fluoro-hexahydro-sila-difenidol and thdr quatemary (N-methylated) analogues by a carbon atom did not change their binding affinities significantly. The iour muscarinic receptors showed a higher affinity for the (R)- than for the (S)-enantiomers of hexahydro-difenidol, p-fluorohexahydro-difenidol and their methiodides. The stereoselectivity varied depending on the receptor subtype and drug considered.
(R)-Hexahydro-difenidol has a higher affinity for M\(_1\) receptors in NB-OK 1 cells, pancreas M\(_3\) and striatum M\(_4\) receptors (pKi 7.9 to 8.3) than for cardiac M2 receptors (pKi 7 .0). (8)-Hexahydro-difenidol, by contrast, is nonselective (pKi 5.8 to 6.1). Our goal in the present study was to evaluate the importance ofthe hydrophobic phenyl, and cyclohexyl rings of hexahydro-difenidol for the stereoselectivity and reeeptor selectivity of hexahydro-difenidol binding to the four muscarinic receptors. Our results indieated that replacement of the phenyl ring of hexahydro-difenidol by a cyclohexyl group <~ dicyclidol) and ofthe cyclohexyl ring by a phenyl moiety <~ difenidol) indueed a !arge (4- to 80-fold) decrease in binding affinity for all musearlnie receptors. Difenidol had a signifieant preference for M\(_1\) , M\(_3\) , and M\(_4\) over M\(_2\) receptors; dicyclidol, by eontrast, had a greater affinity for M\(_1\) and M\(_4\) than for M\(_2\) and M\(_3\) receptors. The binding free energy deerease due to replacement ofthe phenyl and the cyelohexyl groups of(R)-hexahydro-difenidol by, respectively, a eyclohexyl and a phenyl moiety was almostadditive in the ease of M\(_4\) (striatum) binding sites. In the ease ofthe cardiac M\(_2\), pancreatic M\(_3\) , or NB-OK 1 M\(_1\) receptors the respective binding free energies were not eompletely additive. These results suggest that the four (R)-hexahydro-difenidol ''binding moieties" (phenyl, cyclohexyl, hydroxy, and protonated amino group) cannot simultaneously form optimal interaetions with the M\(_1\), M\(_2\), and M\(_3\) muscarinic receptors. When eaeh of the hydrophobic groups is modified, the position of the whole molecule, relative to the four subsites, was changed to allow an optimal overall interaction with the musearlnie receptor.
The enantiomers of the antimuscarinic agent 1-cyclohexyl-1- (4-fluorophenyl)-4-piperidino-1-butanol [(R)- and (S)-p-fluorohexahydro- difenidol] ((R)- and (S)-2a] and their methiodides (R)- 3 and (S)-3 were prepared with high enantiomeric purity. (R)- 2a and (S)-2a (isolated as hydrochlorides) were obtained by catalytic hydrogenation (Pd/C contact) of the corresponding enantiomers of 1-cyclohexyl-1-( 4-fl uorophen yl)-4-piperidino- 2-butyn-1-ol [(R)- and (S)-4]. Reaction of (R)-2a and (S)-2a with rnethyl iodide led to (R)-3 and (S)-3, respectively. The unsaturated precursors (R)- and (S}-4 (enantiorneric purity ~ 99.80 and ~99.94% e.e.; calorimetric analysis) were prepared by res-sepaolution of rac-4 [available from 4-FC\(_6\)H\(_4\)C(O)C\(_6\)H\(_{11}\) by reaction with LiC ~ CCH\(_2\)NC\(_5\)H\(_{10}\)] using (R)- and (S)-mandelic acid as resolving agents. The absolute configurations of the (R) and (S) enantiomers of 2a, 3, and 4 were determined by an X-ray crystal-structure analysis of (S)-5, the methiodide of (S)-4. (R)- 2a and (R)-3 exhibit a higher affinity for muscarinic M1, M2, M3, and M4 receptors (by up to two orders of magnitude) than their corresponding antipodes (S)-2a and (S)-3, the degree of stereoselectivity depending on the receptor subtype involved. (R)-2a represents a useful tool for rnuscarinic receptor research (affinity profile: M1 ~ M3 ~ M4 > M2).
Racemic dimethylphenyl(l-(phenylacetamido)ethyl)silane [rac-5) has been made by a four-step synthesis starting from (chloromethyl)dimethylphenylsilane [PhMe\(_2\)SiCH2Cl (1) ~ PhMe\(_2\)SiCH(Cl)Me (rac-2) - PhMe\(_2\)SiCH(l)Me (rac-3) - PhMe2SiCH(NH2)Me (rac-4) ~ PhMe\(_2\)SiCH[N(H)C(O)CH\(_2\)Ph]Me ( rac-5); total yield 41% ). Enantioselective enzymatic hydrolysis of rac-5, catalyzed by immobilized penicillin G acylase (E.C. 3.5.1.11) from Escherichia coli 5K (pHM 12), gave (R)-(1- aminoethyl)dimethylphenylsilane [( R )-4] in 40% yield with an enantiomeric purity of 92% ee.
Four different syntheses of the potent and selective muscanruc antagonist cyclohexyl( 4- fluorophenyl)(3-piperidinopropyl)silanol ( p-fluoro-hexahydro-sila-difenidol, p-F-HHSiD (2b); isolated as hydrochloride 2b· HCl) are described (starting materials: (CH\(_3\)O)\(_2\)SiCH\(_2\)CH\(_2\)CH\(_2\)Cl and Si(OCH\(_3\))\(_4\) ). In addition, the synthesis of the corresponding carbon analogue p-fluoro-hexahydro-difenidol ( p-F-HHD (2a); isolated as 2a· HCI) and the syntheses of three p-F-HHSiD derivatives (3-5), with a modified cyclic amino group, are reported (3: piperidinojpyrrolidino exchange, isolated as 3· HCI; 4: piperidinoj hexamethylenimino exchange, isolated as 4 · HCl; 5: quaternization of 2b with methyl iodide). The chiral compounds 2a, 2b, 3, 4 and 5 were prepared as racemates. In functional pharmacological studies, 3-5 behaved as simple competitive antagonists at musearlnie Ml receptors in rabbit vas deferens, M2 receptors in guinea-pig atria, and M3 receptors in guinea-pig ileal smooth rnuscle. The pyrrolidino (3) and hexamethylenimino (4) analogues of the parent drug p-F-HHSiD (2b) displayed the highest affinity for Ml and M3 receptors (pA\(_2\) values: 7.0-7.4) but exhibited lower affinity for cardiac M2 receptors (pA\(_2\) : 5.9 and 6.0). Their affinity profile (Ml- M3 > M2) is different from that of p-F-HHSiD (2b) (M3 > Ml > M2), but qualitatively very similar tothat of p-F-HHD (2a). The methiodide 5 exhibited the highest affinity for Ml receptors (pA\(_2\) : 8.5) but lower affinity for M2 and M3 receptors by factors of 5.6 and 3.6, respectively.
Studies were performed in the rabbit aortic rings, precontracted with norepinephrine, to determine the subtype(s) of muscarinic receptors involved in endothelium-dependent relaxation and contraction in the absence of endothelium elicited by cholinergic stimuli. Acetylcholine (ACh) and arecaidine propargyl ester (APE), a M2 and M3 agonist, produced a dose-dependent relaxation and contraction in endothelium-intact and endothelium-denuded rabbit aortic rings, respectively. Both of these responses were blocked by the muscarinic receptor antagonist atropine. M1 selective agonist McN-A-343 [4-[N-(3-chlorophenyl)carbamoyloxy]-2-butinyltrimethylammonium+ ++ chloride] did not produce any effect on the tone of precontracted aortic rings. ACh- and APE-induced relaxation in aortic rings with intact endothelium was selectively blocked by M3 receptor antagonists hexahydrosila-difenidol and p-fluoro-hexahydro-sila-difenidol (pA2 of 7.84 and 7.18) but not by M1 antagonist pirenzepine or M2 receptor antagonists AF-DX 116 [11-(2-[(diethylamino)methyl]- 1-piperidinyl]acetyl)-5, 11-dihydro-6H-pyrido-[2,3-b][1,4]-benzo-diazepin-6-one] and methoctramine. ACh- and APE-induced contraction was inhibited by M2 receptor antagonists AF-DX 116 and methoctramine (pA2 of 7.11 and 6.71) but not by pirenzepine, hexahydro-sila-difenidol or p-fluoro-hexahydro-sila-difenidol. ACh- and APE-induced relaxation or contraction were not altered by nicotinic receptor antagonist hexamethonium or cyclooxygenase inhibitor indomethacin. These data suggest that relaxation elicited by cholinergic stimulin in endothelium-intact aortic rings is mediated via release of endothelium-derived relaxing factor consequent to activation of M3 receptors located on endothelial cells, whereas the contraction in aortic rings denuded of their endothelium is mediated via stimulation of M2 receptors located on smooth muscle cells.
Quasirelativistic and nonrelativistic lo-valence-electronp seudopotentialsf or Ca, Sr, and Ba are presented. Results of calculations with 6s6p5d basis sets for MH, MH\(^+\) , and MH\(_2\), are compared with all-electron and 2-valence-electron pseudopotential calculations with and , without core-polarization potentials. The lo-valence-electron pseudopotential approach agrees well with all-electron calculations. It circumvents problems for the 2-valence-electron pseudopotentials arising from an incomplete separation of valence and subvalence shells in polar molecular systems due to strongly contracted occupied (n - 1 )-d orbitals. All higherlevel calculations show SrH\(_2\) and BaII\(_2\), to be bent with angles of - 140° and 120°, respectively, while CaH\(_2\) is linear with a flat potential-energy surface for the bending motion. The use of a core-polarization potential together with the 2-valence-electronp seudopotentiala pproach allows an investigation of the relative importance of core-polarization vs direct d-orbital bonding participation as reasons for the bent structures. The calculations strongly suggest that both contribute to the bending in SrH\(_2\) and BaII\(_2\). Even at the Hartree-Fock level of theory lovalence- electronp seudopotentialc alculations given reasonablea nglesw hen the potentialenergy surface is not exceedingly flat, and only moderately contracted basis sets including both compact d functions and diffuse p functions are used. The effect of core-valence correlation and the importance off functions also are discussed.
Chiral 2-alkylbranched acids, esters and alcohols. Preparation and stereospecific flavour evaluation
(1991)
Racemic 2-alkylbranched acids are transformed to diastereomeric derivatives with (S)-2-hydroxy-3-phenylpropionic acid-N-methylamide or (S)-(-)-l-phenylethylamine and separated by liquid chromatography to pure diastereoisomers, which are subsequently hydrolyzed to yield optically pure acids. Enantiomeric alcohols are generated by LiAlH4-reduction of the corresponding acids, esters are synthesized by different methods. The odour impression of the enantiomeric compounds is investigated.
A practicable two-step procedure for the preparation of a series of lactone-type bridged biaryls 7 as favorable substrates for subsequent atropisomer-selective ring-opening reactions is described. Due to the efficiency of the coupling step, which tolerates even a telt·butyl group next to the biaryl axis and avoids problems of regioselectivity, a variety of differently substituted representatives is prepared. These cover a broad range of steric hindrance and thus molecular distortion. The structures are investigated mainly by NMR spectroscopy and X-ray diffraction, showing the lactones 7 to be helically distorted, depending on the size of the residues R.
Bis( 4-fluorophenyl)methyl(l H-1,2,4-triazol-1-yl-methyl)germane (2), a germanium analogue of the agricultural fungicide flusilazole (1), has been synthesized from Cl\(_3\)GeCH\(_2\)CI (3) by both a three-step and a four-step synthesis (3-> (p-F-C\(_6\)H\(_4\))\(_2\)Ge(CH\(_2\)Cl)Br (4)-> (p-F-C\(_6\)H\(_4\))\(_2\)Ge(CH\(_2\)CI)CH\(_3\) (S)-> 2; S ~ (p-F-C\(_6\)H\(_4\))\(_2\)Ge(CH\(_2\)I)CH\(_3\) (6)-> l). The fungicidal properties of l have been compared with those of the parent silicon compound 1 (studies on Si/Ge bioisosterism). In various test systems, the SijGe analogues 1 and 2 showed comparable fungicidal properlies (in activity against plant pathogenic fungi: in agar plate diffusion tests and greenhause evaluations; in activity against human pathogenic fungi: in serial dilution tests). In addition, 1 and 2 displayed comparable potencies in respect of sterol biosynthesis inhibition in Sacclulromycopsis üpolytica and Pyricularia oryzae, the mode of action being primarily an inhtbition of oxidative C14-demethylation.
Wc invcstigatcd thc binding properlies of thc (R)- and (Sl-cnantiomcrs of thc muscarinic antagonists trihcxyphcnidyl, procyclidinc, hcxahydro-difcnidol. p-fluoro-hcxahydro-difcnidol. hcxbutinol, p-fluoro-hcxbutinnl. and thcir corrcsponding methiodidcs at muscarinic M\(_1\), M\(_2\)• M\(_3\) and M\(_4\) receptor subtypes. In addition. binding properlies of thc (R)- and (S)-cnantiomcrs of oxyphcncycliminc wcrc studicd. The {R)- cnantiomcrs (cutomcrs} of all the compounds had a grcatcr affinity than the (S)-isomcrs for thc four muscarinic rcccptor subtypcs. Thc binding pattcrns of thc (R)- and (S)-enantiomers wcrc gcncrally different. We did not obscrvc any gcncral corrclation hctwccn thc potcncy of thc high-affinity enantiomer and Lhc affinity ratio (cudismic ratio) of the two cnantiomcrs. Thc rcsuhs arc discusscd in tcrms of a 'four suhsitcs' binding modcl.
Muscarinic receptors of rcsistance vessels (submucosal artcrioles, outside diametcr 50-75 J,Lm) from the guinea-pig small intestinc were invcstigatcd in vitro using a computcr-assisted vidcomicroscopy system (Diamtrak <~t ). The muscarinic receptor which mediates vasodilation of prccontractcd [U-46619 (300 nM) or (- )-noradrcnaline (1 0 J.L M)] artcriolcs was characterized with scveral muscarinic agonists and subtypc-sclectivc antagonists. Thc following agonists all produccd cquivalent maximum vasodilation (given in rank ordcr of potency): acctylcholinc = arccaidinc propargyl cstcr (APE) > oxotremorine = ( ± )-muscarinc = ( ± )-mcthacholinc > carbachol > 4-[[N-{4-chlorophenyl)carbamoyl]oxy]-2-hutynyltrimcthylammonium iodide (4-CI-McN-A- 343). 4-([N-(3-ChlorophcnyD-carbamoyl)oxy]-2-butynyltrimcthylammonium chloride (McN-A-343) and N-ethyl-guvacinc propargyl ester (NEN-APE) produccd minimal or no artcriolar vasodilation. Thc muscarinic antagonists pircnzcpinc, ( ± )-5,11-dihydro-11- [[[2-[2-((dipropylamino)methyl}-1-pipcridinyl]ethyl]amino ]-carbonyi]-6H-pyrido(2,3-h)( 1 ,4)-benzodiazcpin-6-onc (AF-DX 384 ), 11- [[ 4-[4-(dicthylamino)butyl]-1-piperidinyl]acetyl]-5, ll-dihydro-6H-pyrido(2.3-h)( 1,4 )-bcnzodiazepin-6-onc (AQ-RA 741 ), p-fluorohexahydro- sila-difcnidol (p-F-HHSiD), 4-diphcnylacetoxy-N-methylpipcridine mcthiodidc (4-DAMP) and (R)- and (S)hexahydro- difcnidol [(R)-HHD, (S)-HHD] shifted thc muscarinc, mcthacholinc or carbachol dosc-rcsponsc curve to the right in a compctitive manner. Schildanalysis of the data yicldcd pA\(_2\) valucs for pircnzcpinc (6.74/6.9), AF-DX 384 (6.72), AQ-RA 741 (6.58), p-F-HHSiD (7.53/7.57), 4-DAMP (9.06), (R)-HHD (7.88/8.32) and (S)-HHD (5.52/5.88). Thus, it can he concluded that submucosal arteriolcs posscss only the M\(_3\) functional muscarinic reccptor, the activation of which causcs hlood vcsscl dilation. The preparation dcscribcd is considcrcd to be a valuable now bioassay for pharmacological investigations of drug actions at muscarinic receptors in the peripheral vascular system.